I see that ORD MINNETT has maintained its speculative buy with a 53 cents price in the latest issue on the PRR website posted after the recent CAN3 results.
http://www.primabiomed.com.au/announcements/pm/608.php
Again along with the Nomura Report this reinforces the official view of the PRR management team that it is on the right track with results so far deeming all aspects of the purpose of the trial a success.
cheers
Birdseye
om maintain spec buy of 53 cents
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 188729 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 46153 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |